What is he best known for?
The fields of study he is best known for:
- Cancer
- Gene
- Internal medicine
Melanoma, Cancer research, Cancer, Internal medicine and Oncology are his primary areas of study.
His work carried out in the field of Melanoma brings together such families of science as Immune checkpoint, Immunotherapy, Immunology, Disease and Programmed cell death.
He interconnects Protein kinase B, Cell growth, Immune system and PI3K/AKT/mTOR pathway, PTEN in the investigation of issues within Cancer research.
His Cancer study combines topics from a wide range of disciplines, such as Mutation and Genome-wide association study.
His research investigates the connection between Internal medicine and topics such as Surgery that intersect with issues in Cohort.
His Oncology research incorporates elements of Clinical trial, Phases of clinical research, Retrospective cohort study, Genotype and Binimetinib.
His most cited work include:
- A landscape of driver mutations in melanoma (1701 citations)
- Genomic Classification of Cutaneous Melanoma (1491 citations)
- Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients (1381 citations)
What are the main themes of his work throughout his whole career to date?
Michael A. Davies mainly focuses on Melanoma, Cancer research, Internal medicine, Oncology and Cancer.
His biological study deals with issues like Neuroblastoma RAS viral oncogene homolog, which deal with fields such as MEK inhibitor and Cutaneous melanoma.
As a part of the same scientific family, Michael A. Davies mostly works in the field of Cancer research, focusing on PTEN and, on occasion, Tumor suppressor gene.
In the subject of general Internal medicine, his work in Metastatic melanoma, Dabrafenib and Clinical trial is often linked to In patient, thereby combining diverse domains of study.
His work deals with themes such as Surgery, Phases of clinical research, Blockade, Nivolumab and Ipilimumab, which intersect with Oncology.
His work in Cancer tackles topics such as Disease which are related to areas like Bioinformatics.
He most often published in these fields:
- Melanoma (60.05%)
- Cancer research (43.97%)
- Internal medicine (35.70%)
What were the highlights of his more recent work (between 2018-2021)?
- Melanoma (60.05%)
- Cancer research (43.97%)
- Internal medicine (35.70%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Melanoma, Cancer research, Internal medicine, Oncology and Cancer.
The study incorporates disciplines such as Immune checkpoint, Immune system, Immunotherapy, Targeted therapy and Primary tumor in addition to Melanoma.
His Cancer research research incorporates themes from Cell, Brain metastasis, Downregulation and upregulation, PI3K/AKT/mTOR pathway and In vivo.
His biological study spans a wide range of topics, including Trametinib and Cutaneous melanoma.
His Oncology study combines topics in areas such as MEK inhibitor, Metastatic melanoma, Clinical trial and Systemic therapy.
His Cancer research includes themes of Gene, DNA sequencing and Incidence.
Between 2018 and 2021, his most popular works were:
- B cells and tertiary lymphoid structures promote immunotherapy response (330 citations)
- Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma. (278 citations)
- Molecular Profiling Reveals Unique Immune and Metabolic Features of Melanoma Brain Metastases. (81 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Gene
- Internal medicine
Michael A. Davies mostly deals with Melanoma, Internal medicine, Oncology, Cancer research and Immune system.
His Melanoma research incorporates elements of Cyclin-dependent kinase 4, Cyclin-dependent kinase 6, Cyclin-dependent kinase 2, Proportional hazards model and Hazard ratio.
His Oncology research is multidisciplinary, incorporating elements of Cancer, Immunotherapy, Clinical trial, MEK inhibitor and Systemic therapy.
His work deals with themes such as Incidence, Microarray and Gene duplication, Gene, DNA sequencing, which intersect with Cancer.
His Cancer research study combines topics from a wide range of disciplines, such as Cell growth, MAPK/ERK pathway, CD8, Metastasis and In vivo.
His research investigates the link between Metastasis and topics such as Focal adhesion that cross with problems in Protein kinase B.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
